institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Weight Loss: Can Ozempic, Other GLP-1 Drugs Boost Low Testosterone?

ST. LOUIS, MISSOURI, JUL 15 – New research shows GLP-1 receptor agonists raised testosterone by 18% and normalized levels in 77% of men with obesity or type 2 diabetes after 18 months.

Summary by Healthline
A new study reports that GLP-1 medications may improve low testosterone in men with obesity or type 2 diabetes. The findings align with prior evidence showing that weight loss can support healthy testosterone levels.Read MoreThe post GLP-1 Drugs May Boost Testosterone Levels In Men With Obesity, Diabetes first appeared on The Who Dat Daily.

11 Articles

Lean Left

Celebrities and public figures drive the use of weight loss drugs. The danger of following trends without medical supervision. Physical and emotional consequences that many do not know

·Buenos Aires, Argentina
Read Full Article

The European Medicines Agency has assessed the eye disease NAION as a very rare side effect of the semaglutide medicines (Ozempic, Rybelsus and Wegovy) prescribed for diabetes and weight loss. Semaglutide should be stopped if a patient is diagnosed with NAION. NAION, or anterior optic neuropathy, is a condition in which the front part of the optic nerve, the optic plexus, is deprived of oxygen due to a lack of blood flow. It can cause sudden and…

A new obesity pill that can burn fat without suppressing appetite is showing promise in animal tests and early human clinical trials, and if proven, could offer a more convenient and cheaper alternative to the GLP-1 drugs that currently dominate the market.

Users of an app recognize positive and negative effects, such as raising libido and self-esteem but also feeling more stigma and shame, according to a study by US scientists

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources lean Left
67% Left

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

urologytimes.com broke the news in on Tuesday, July 15, 2025.
Sources are mostly out of (0)